Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Yan R, Corman A, Katgara L, Wang X, Xue X, Gajic Z
Nat Biotechnol. 2024; .
PMID: 39572737
DOI: 10.1038/s41587-024-02475-x.
Yang Y, Huang Z, Luo J, He J, Shi L, Chen G
IET Syst Biol. 2024; 18(5):183-198.
PMID: 39370684
PMC: 11490192.
DOI: 10.1049/syb2.12099.
He D, Cui B, Lv H, Lu S, Zhu Y, Cheng Y
Biomolecules. 2024; 14(7).
PMID: 39062561
PMC: 11275243.
DOI: 10.3390/biom14070847.
Duman C, Di Marco B, Nevedomskaya E, Ulug B, Lesche R, Christian S
Cell Death Dis. 2023; 14(4):296.
PMID: 37120445
PMC: 10148872.
DOI: 10.1038/s41419-023-05813-0.
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.
Jones D, Whitehead C, Dinevska M, Widodo S, Furst L, Morokoff A
Mol Cell Biochem. 2022; 478(6):1251-1267.
PMID: 36302993
PMC: 10164021.
DOI: 10.1007/s11010-022-04584-0.
Metabolic modeling-based drug repurposing in Glioblastoma.
Tomi-Andrino C, Pandele A, Winzer K, King J, Rahman R, Kim D
Sci Rep. 2022; 12(1):11189.
PMID: 35778411
PMC: 9249780.
DOI: 10.1038/s41598-022-14721-w.
SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer.
Hou W, Li G, Gao L, Lu H, Zhou H, Kong J
BMC Med Genomics. 2022; 15(1):114.
PMID: 35581615
PMC: 9112447.
DOI: 10.1186/s12920-022-01266-0.
Chromoanagenesis Event Underlies a Pericentric and Multiple Paracentric Inversions in a Single Chromosome Causing Coffin-Siris Syndrome.
Grochowski C, Krepischi A, Eisfeldt J, Du H, Bertola D, Oliveira D
Front Genet. 2021; 12:708348.
PMID: 34512724
PMC: 8427664.
DOI: 10.3389/fgene.2021.708348.
PI(3,4)P-mediated membrane tubulation promotes integrin trafficking and invasive cell migration.
Feng Z, Yu C
Proc Natl Acad Sci U S A. 2021; 118(19).
PMID: 33947811
PMC: 8126793.
DOI: 10.1073/pnas.2017645118.
Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma.
Zhang R, Mo W, Huang L, Chen J, Wu W, He W
Bioengineered. 2021; 12(1):855-874.
PMID: 33641617
PMC: 8806346.
DOI: 10.1080/21655979.2021.1890399.
PTEN and Other PtdIns(3,4,5)P Lipid Phosphatases in Breast Cancer.
Csolle M, Ooms L, Papa A, Mitchell C
Int J Mol Sci. 2020; 21(23).
PMID: 33276499
PMC: 7730566.
DOI: 10.3390/ijms21239189.
Inhibition of invadopodia formation by diosgenin in tumor cells.
Lian Y, Wen D, Meng X, Wang X, Li H, Hao L
Oncol Lett. 2020; 20(6):283.
PMID: 33014161
PMC: 7520800.
DOI: 10.3892/ol.2020.12148.
Leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in Glioblastoma Cell Invasion and Resistance.
Ding Z, Dong Z, Yang Y, Fortin Ensign S, Sabit H, Nakada M
Am J Pathol. 2020; 190(10):2165-2176.
PMID: 32693062
PMC: 7527857.
DOI: 10.1016/j.ajpath.2020.07.005.
A proximity-labeling proteomic approach to investigate invadopodia molecular landscape in breast cancer cells.
Thuault S, Mamelonet C, Salameh J, Ostacolo K, Chanez B, Salaun D
Sci Rep. 2020; 10(1):6787.
PMID: 32321993
PMC: 7176661.
DOI: 10.1038/s41598-020-63926-4.
The Cytoskeleton-A Complex Interacting Meshwork.
Hohmann T, Dehghani F
Cells. 2019; 8(4).
PMID: 31003495
PMC: 6523135.
DOI: 10.3390/cells8040362.
Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.
Whitehead C, Nguyen H, Morokoff A, Luwor R, Paradiso L, Kaye A
Transl Oncol. 2018; 11(6):1406-1418.
PMID: 30219696
PMC: 6140414.
DOI: 10.1016/j.tranon.2018.08.012.
The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.
Ramos A, Ghosh S, Erneux C
J Lipid Res. 2018; 60(2):276-286.
PMID: 30194087
PMC: 6358294.
DOI: 10.1194/jlr.R087908.
Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.
Poudel K, Roh-Johnson M, Su A, Ho T, Mathsyaraja H, Anderson S
Dev Cell. 2018; 45(6):738-752.e6.
PMID: 29920278
PMC: 6095642.
DOI: 10.1016/j.devcel.2018.05.021.
Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.
Kou C, Kandpal R
Biomed Res Int. 2018; 2018:7390104.
PMID: 29682554
PMC: 5851329.
DOI: 10.1155/2018/7390104.